Wegovy Cut Heart Attack, Stroke Risks by 20%, Study Finds
A Novo Nordisk study claims its Wegovy weight loss drug can reduce the risk of heart attacks, strokes and cardiovascular death by 20%.
Injured by Ozempic, Wegovy or Mounjaro?
Tag Archives: Weight Loss
-
-
Novo Nordisk Seeks to Dismiss Lawsuit Over Ozempic Gastrointestinal Side Effects
The manufacturers of Ozempic are moving to have a lawsuit over the drug's gastrointestinal side effects dismissed, claiming that it adequately warned users and the medical community.
-
FDA Approves Mounjaro for Weight Loss Use, to Be Sold Under New Zepbound Name
The FDA has approved a weight loss version of Eli Lilly's diabetes drug, Mounjaro, which will be marketed under the name Zepbound.
-
Ozempic Class Action Lawsuit Over Gastroparesis Risk Filed in Canada
An Ozempic class action lawsuit filed in Canada claims the manufacturer knew about the risks of gastroparesis but failed to adequately notify the medical community and patients of the stomach…
-
EMA Finds No Link Between Thyroid Cancer and Ozempic, Wegovy and Other New Weight Loss Drugs
European drug regulators, who previously warned Ozempic and similar drugs may be linked to thyroid cancer, now say there is no data to back up the claims of cancer risk.
-
Qsymia More Cost-Effective Weight Loss Treatment for Children Than Ozempic, Wegovy: Study
A new study finds that Qsymia is more cost effective than Ozempic and similar drugs at providing weight loss benefits for obese children.
-
Wegovy Class Action Lawsuit Filed Against Health Insurers for Not Covering Obesity Treatment
A class action lawsuit filed in Washington state accuses a state-run health insurer of discrimination for failing to cover her Wegovy weight loss prescription.
-
Side Effects of Ozempic, Wegovy, Similar Drugs Increase Risk of Stomach Paralysis and Pancreatitis: Study
Canadian researchers warn that the side effects of Ozempic and similar diabetes drugs being used for weight loss increase the risk of pancreatitis, bowel obstruction and stomach paralysis.
-
Microbial Contaminant Control Problems at Ozempic Manufacturing Facility Has Resulted in FDA Investigator Warning
A new report reveals FDA inspectors found a lack of adequate microbial controls at a Novo Nordisk plant in the U.S., which manufactures the active ingredient for Ozempic and Wegovy.
-
Ozempic Stomach Risks Result in Debate Among Anesthesiologists Over Surgery Guidelines
Some anesthesiologists are saying recent ASA guidelines don't go far enough to prevent Ozempic stomach risks during surgery.
